Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Narcolepsy With Cataplexy”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableStudy completedNCT05314556
What this trial is testing

Group Psychotherapy in Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Cantonal Hospital of St. Gallen 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT05914194
What this trial is testing

A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1Narcolepsy With Cataplexy
NLS Pharmaceutics 48
Large-scale testing (Phase 3)Study completedNCT02221869
What this trial is testing

Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy

Who this might be right for
Narcolepsy With Cataplexy
Jazz Pharmaceuticals 106
Testing effectiveness (Phase 2)Study completedNCT04072380
What this trial is testing

Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Who this might be right for
Narcolepsy
Suven Life Sciences Limited 190
Large-scale testing (Phase 3)Study completedNCT05113745
What this trial is testing

Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Axsome Therapeutics, Inc. 68
Large-scale testing (Phase 3)Study completedNCT00078377
What this trial is testing

Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy

Who this might be right for
Narcolepsy
Cephalon 196
Large-scale testing (Phase 3)Study completedNCT01067235
What this trial is testing

Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Bioprojet 14
Testing effectiveness (Phase 2)Ended earlyNCT04096560
What this trial is testing

TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT1)Narcolepsy Type 2 (NT2)
Takeda 97
Not applicableLooking for participantsNCT05615584
What this trial is testing

Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence

Who this might be right for
NarcolepsyIdiopathic HypersomniaCataplexy
University Hospital, Montpellier 117
Not applicableStudy completedNCT01394614
What this trial is testing

Risk of Narcolepsy Associated With Administration of H1N1 Vaccine

Who this might be right for
Narcolepsy
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 24
Not applicableLooking for participantsNCT06383806
What this trial is testing

Decreasing Nightmares in Adults With Narcolepsy

Who this might be right for
NarcolepsyNarcolepsy Type 1Narcolepsy With Cataplexy+3 more
University of Utah 80
Large-scale testing (Phase 3)Study completedNCT01399606
What this trial is testing

Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)

Who this might be right for
NarcolepsyCataplexy
Bioprojet 102
Testing effectiveness (Phase 2)Study completedNCT00075959
What this trial is testing

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Who this might be right for
Intracerebral Hemorrhage
AstraZeneca 600
Large-scale testing (Phase 3)Study completedNCT04451668
What this trial is testing

An Open Label Study of FT218 in Subjects With Narcolepsy

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Somnolence+3 more
Avadel 184
Testing effectiveness (Phase 2)Study completedNCT05055024
What this trial is testing

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Who this might be right for
Narcolepsy With CataplexyNarcolepsyNarcolepsy Without Cataplexy
NLS Pharmaceutics 52
Early research (Phase 1)Study completedNCT05015673
What this trial is testing

This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation.

Who this might be right for
Narcolepsy
Otsuka Pharmaceutical Development & Commercialization, Inc. 18
Large-scale testing (Phase 3)Study completedNCT06470828
What this trial is testing

TAK-861 for the Treatment of Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Takeda 168
Testing effectiveness (Phase 2)Ended earlyNCT04820842
What this trial is testing

TAK-994 in Adults With Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT 1)
Takeda 26
Not applicableStudy completedNCT00174174
What this trial is testing

Provigil (Modafinil) Study by Taiwan Biotech Co.

Who this might be right for
NarcolepsyCataplexySleep Disorders+2 more
National Taiwan University Hospital 30
Early research (Phase 1)Study completedNCT01093508
What this trial is testing

Single-dose Safety Study of APD916 in Healthy Volunteers

Who this might be right for
Narcolepsy With or Without Cataplexy
Arena Pharmaceuticals 72
Load More Results